Literature DB >> 12721366

SPARC-null mice exhibit increased adiposity without significant differences in overall body weight.

A D Bradshaw1, D C Graves, K Motamed, E H Sage.   

Abstract

Secreted protein acidic and rich in cysteine/osteonectin/BM-40 (SPARC) is a matrix-associated protein that elicits changes in cell shape, inhibits cell-cycle progression, and influences the synthesis of extracellular matrix (ECM). The absence of SPARC in mice gives rise to aberrations in the structure and composition of the ECM that result in generation of cataracts, development of severe osteopenia, and accelerated closure of dermal wounds. In this report we show that SPARC-null mice have greater deposits of s.c. fat and larger epididymal fat pads in comparison with wild-type mice. Similar to earlier studies of SPARC-null dermis, we observed a reduction in collagen I in SPARC-null fat pads in comparison with wild-type. Although elevated levels of serum leptin were observed in SPARC-null mice, their overall body weights were not significantly different from those of wild-type counterparts. The diameters of adipocytes from SPARC-null versus wild-type epididymal fat pads were 252 +/- 61 and 161 +/- 33 microm (means +/- SD), respectively, and there was an increase in adipocyte number within SPARC-null fat pads in comparison with wild-type pads. Thus the absence of SPARC appears to result in an increase in the size of individual adipocytes as well as an increase in the number of adipocytes per fat pad. In fat pads isolated from wild-type mice, SPARC mRNA was associated with both the stromal/vascular and adipocyte fractions. We propose that SPARC limits the accumulation of adipose tissue in mice in part through its demonstrated effects on the regulation of cell shape and production of ECM.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12721366      PMCID: PMC156323          DOI: 10.1073/pnas.1030790100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  Obesity and the regulation of energy balance.

Authors:  B M Spiegelman; J S Flier
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  Spectral studies on 33258 Hoechst and related bisbenzimidazole dyes useful for fluorescent detection of deoxyribonucleic acid synthesis.

Authors:  S A Latt; G Stetten
Journal:  J Histochem Cytochem       Date:  1976-01       Impact factor: 2.479

3.  A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation.

Authors:  S Selvarajan; L R Lund; T Takeuchi; C S Craik; Z Werb
Journal:  Nat Cell Biol       Date:  2001-03       Impact factor: 28.824

4.  Osteopenia and decreased bone formation in osteonectin-deficient mice.

Authors:  A M Delany; M Amling; M Priemel; C Howe; R Baron; E Canalis
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 5.  SPARC, a matricellular protein: at the crossroads of cell-matrix.

Authors:  R A Brekken; E H Sage
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

6.  SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells.

Authors:  A Francki; A D Bradshaw; J A Bassuk; C C Howe; W G Couser; E H Sage
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

7.  Vascular smooth muscle cells spontaneously adopt a skeletal muscle phenotype: a unique Myf5(-)/MyoD(+) myogenic program.

Authors:  D C Graves; Z Yablonka-Reuveni
Journal:  J Histochem Cytochem       Date:  2000-09       Impact factor: 2.479

8.  Lenses of SPARC-null mice exhibit an abnormal cell surface-basement membrane interface.

Authors:  K Norose; W K Lo; J I Clark; E H Sage; C C Howe
Journal:  Exp Eye Res       Date:  2000-09       Impact factor: 3.467

9.  Increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges in SPARC-null mice.

Authors:  A D Bradshaw; M J Reed; J G Carbon; E Pinney; R A Brekken; E H Sage
Journal:  Wound Repair Regen       Date:  2001 Nov-Dec       Impact factor: 3.617

10.  Stromelysin-1 regulates adipogenesis during mammary gland involution.

Authors:  C M Alexander; S Selvarajan; J Mudgett; Z Werb
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

View more
  75 in total

Review 1.  ECM roles in the function of metabolic tissues.

Authors:  Guorui Huang; Daniel S Greenspan
Journal:  Trends Endocrinol Metab       Date:  2011-11-08       Impact factor: 12.015

2.  TLR4 activation and IL-6-mediated cross talk between adipocytes and mononuclear cells synergistically stimulate MMP-1 expression.

Authors:  Devadoss J Samuvel; Junfei Jin; Kamala P Sundararaj; Yanchun Li; Xiaoming Zhang; Maria F Lopes-Virella; Yan Huang
Journal:  Endocrinology       Date:  2011-09-27       Impact factor: 4.736

3.  Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets.

Authors:  N Viguerie; H Vidal; P Arner; C Holst; C Verdich; S Avizou; A Astrup; W H M Saris; I A Macdonald; E Klimcakova; K Clément; A Martinez; J Hoffstedt; T I A Sørensen; D Langin
Journal:  Diabetologia       Date:  2004-12-29       Impact factor: 10.122

Review 4.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

Review 5.  The bone-adipose axis in obesity and weight loss.

Authors:  J Gómez-Ambrosi; A Rodríguez; V Catalán; G Frühbeck
Journal:  Obes Surg       Date:  2008-06-19       Impact factor: 4.129

6.  Inflammation: where is the SPARC in adipose-tissue inflammation?

Authors:  Mourad Naïmi; Emmanuel Van Obberghen
Journal:  Nat Rev Endocrinol       Date:  2009-12       Impact factor: 43.330

Review 7.  The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease.

Authors:  Sharon L I Wong; Maria B Sukkar
Journal:  Br J Pharmacol       Date:  2016-11-25       Impact factor: 8.739

8.  Osteopenia in Sparc (osteonectin)-deficient mice: characterization of phenotypic determinants of femoral strength and changes in gene expression.

Authors:  Fiona C Mansergh; Timothy Wells; Carole Elford; Samuel L Evans; Mark J Perry; Martin J Evans; Bronwen A J Evans
Journal:  Physiol Genomics       Date:  2007-09-18       Impact factor: 3.107

9.  SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling.

Authors:  Jing Nie; E Helene Sage
Journal:  J Biol Chem       Date:  2008-11-05       Impact factor: 5.157

Review 10.  Fat fibrosis: friend or foe?

Authors:  Ritwik Datta; Michael J Podolsky; Kamran Atabai
Journal:  JCI Insight       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.